Neurology® Podcast

Dr. Halley Alexander talks with Dr. Shóbi Sivathamboo about the incidence of serious cardiac arrhythmias detected by subcutaneous cardiac monitors in patients with chronic drug-resistant epilepsy. Read the full article in Neurology.

Dr. Jeff Ratliff talks with Dr. Andreas Rowald about the efficacy of activity-dependent spinal cord neuromodulation, which was shown to rapidly restore trunk and leg motor functions in patients with spinal cord injury after complete paralysis.

Dr. Stacey Clardy discusses the prognostic factors and efficacy of immunosuppressive treatments for spinal cord sarcoidosis with Dr. Antoine Gavoille. Read the full article in Neurology.

Dr. Justin Abbatemarco talks with Dr. Bruce Bebo about the estimated economic burden of multiple sclerosis in the US, highlighting direct and indirect cost drivers. Read the full article in Neurology. Please be sure to check out the National Multiple Sclerosis Society's "MS Navigator" resource, which connects patients with MS and their family members to experts who can help them navigate the challenges of MS, from making workplace accommodation requests to case management assessment.

The May 2022 replay of past episodes showcases a selection of interviews about autoimmune neurologic diseases of the central nervous system. This episode features illuminating conversations with Drs. Josep Dalmau, Jérôme Honnorat, and Carles Gaig on the clinical evaluation of first episode psychosis, GFAP autoimmune syndrome, and anti-IgLON5 disease, respectively, as well as a suite of clinical pearls for each syndrome. This month's Recall concludes with a useful series from Dr. Justin...

Dr. Jeff Ratliff talks with Dr. Michael Fox about the association of connectivity between brain networks and sites of deep brain stimulation (DBS) with DBS-induced cognitive decline in patients with Parkinson disease. Check out the free clinical tool designed to help DBS programmers based on the research discussed in this episode here.

Dr. Halley Alexander talks with Dr. Mark Keezer about the risk of sudden death and cardiac arrhythmia in patients utilizing lamotrigine to treat epilepsy. Read the full article in Neurology.

Dr. Gregg Day talks with Dr. Walter Koroshetz, Director of NINDS, about research recommendations, priorities, and outcomes at the 2022 Alzheimer's Disease-Related Dementias (ADRD) Summit.

Dr. Jason Crowell talks with Dr. Gregg Day about amyloid-targeting treatments for Alzheimer disease as well as how to navigate conversations about aducanumab with patients.

Dr. Jeff Ratliff talks with Drs. Howard Colman and Kelly Fritz about the availability of lomustine for the treatment of glioblastoma multiforme (GBM) in light of the drug's recent withdrawal from Medicare Part D coverage.

Dr. Tesha Monteith talks with Dr. Barbara Decker about maternal obstetric complications and non-elective postpartum readmissions in women with prior stroke, migraine, multiple sclerosis, and myasthenia gravis. Read the full article in Neurology.

Dr. Justin Abbatemarco talks with Dr. Aurora Pujol about diagnosing genetic white matter disorders by singleton whole-exome and whole-genome sequencing using interactome-driven prioritization. Read the full article in Neurology.

Dr. Tesha Monteith talks with Dr. Todd Schwedt about the treatment of chronic migraine with medication overuse through the patient-centered Medication Overuse Treatment Strategy (MOTS) clinical trial. Read the full article in Neurology.

The April 2022 replay of past episodes showcases a selection of interviews with fellow neurologists about their personal experiences as patients. This episode features illuminating conversations with Drs. Daniel Drubach, Daniel Gibbs, Ted Burns, and Oliver Sacks, offering our listeners essential lessons and insights into the importance of physician empathy.

Dr. Gordon Smith talks with Dr. Charlotte Sumner about spinal muscular atrophy, highlighting the historic milestone reached with three medications receiving FDA approval for the treatment of SMA.

Dr. Jason Crowell talks with Drs. Ariane Lewis and David Magnus about the need to update the Uniform Declaration of Death Act (UDDA), aligning the legal criteria with the medical standards used to determine death by neurological criteria. Read the full article in Neurology.

Dr. Jeff Burns talks with Dr. Lon Schneider about the development of ARIA in the Phase 3 EMERGE and ENGAGE trials that led to the FDA's accelerated approval of aducanumab for the treatment of Alzheimer disease.

Dr. Alex Menze talks with Dr. Raquel Gardner about the development of a clinically-relevant definition of poor cognitive outcome one year after mild traumatic brain injury (mTBI) and whether outcomes can be predicted by baseline clinical variables. Read the full article in Neurology.

This episode features Dr. Stacey Clardy in conversation with the 2022 Ted Burns Humanism in Neurology Award Winner, Dr. Barbara Giesser.

Dr. Gregg Day talks with Dr. Niklas Mattsson-Carlgren about the correlation of cerebrospinal fluid biomarkers with autopsy-confirmed Alzheimer disease and frontotemporal lobar degeneration. Read the full article in Neurology.